Search

everythinglearnresearchcommunity

for

Search:↓

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Oral minoxidil helps hair growth, is cost-effective, and mostly well-tolerated.

Most adult women experiencing hair loss are aged 21-40, with the most common type being female pattern hair loss. Trichoscopy is a useful tool for diagnosing different types of hair loss.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Low-dose oral minoxidil is an effective and safe treatment for hair loss.

Eating more protein during weight loss can prevent hair loss caused by not having enough protein.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.

New treatments for hair loss show promise, including plasma, stem cells, and hair-stimulating complexes, but more research is needed to fully understand them.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

A new hair loss classification for women improves treatment, but careful patient selection is crucial for successful hair transplantation.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.

Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.

About 61% of women who had COVID-19 experienced hair loss afterward.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.